0001681655-16-000001.txt : 20160811
0001681655-16-000001.hdr.sgml : 20160811
20160811104633
ACCESSION NUMBER: 0001681655-16-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160811
DATE AS OF CHANGE: 20160811
EFFECTIVENESS DATE: 20160811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cx Precision Medicine, Inc.
CENTRAL INDEX KEY: 0001681655
IRS NUMBER: 813152324
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-268736
FILM NUMBER: 161823381
BUSINESS ADDRESS:
STREET 1: 1120 SOUTH FREEWAY
CITY: FORTH WORTH
STATE: TX
ZIP: 76104
BUSINESS PHONE: 8175231301
MAIL ADDRESS:
STREET 1: 1120 SOUTH FREEWAY
CITY: FORTH WORTH
STATE: TX
ZIP: 76104
D
1
primary_doc.xml
X0707
D
LIVE
0001681655
Cx Precision Medicine, Inc.
1120 SOUTH FREEWAY
FORT WORTH
TX
TEXAS
76104
8175231301
DELAWARE
None
None
Corporation
true
2016
Frank
Gerome
1120 South Freeway
Fort Worth
TX
TEXAS
76104
Executive Officer
Director
Director, CEO and President
Biotechnology
Decline to Disclose
- 06b
false
2016-07-12
false
true
true
false
0
1000000
250000
750000
false
1
0
0
0
false
Cx Precision Medicine, Inc.
/s/ Frank Gerome
Frank Gerome
Director, CEO and President
2016-08-10